A 38-year-old man on risperidone for schizophrenia for 6 months presents with galactorrhea and amenorrhea in his female partner. Which finding best distinguishes risperidone-induced hyperprolactinemia from haloperidol-induced hyperprolactinemia?

Explanation

## Risperidone vs. Haloperidol: Hyperprolactinemia Comparison **Key Point:** Both risperidone and haloperidol cause hyperprolactinemia via dopamine D2 antagonism in the tuberoinfundibular pathway, but the degree and clinical significance differ substantially. ### Mechanism of Hyperprolactinemia | Antipsychotic | D2 Affinity (Tuberoinfundibular) | Prolactin Elevation | Clinical Significance | |---|---|---|---| | **Haloperidol (typical)** | Very high; strong D2 blockade | Marked (often >200 ng/mL) | Severe; gynecomastia, galactorrhea, sexual dysfunction | | **Risperidone (atypical)** | High; moderate-to-high D2 blockade | Moderate-to-marked (often 100–150 ng/mL) | Moderate; less severe than haloperidol | | **Aripiprazole (atypical)** | Partial agonist at D2 | Minimal | Least problematic atypical | **High-Yield:** Haloperidol causes **greater prolactin elevation** than risperidone because it has stronger D2 antagonism in the tuberoinfundibular pathway. This is the key discriminator. ### Pathophysiology Dopamine is the physiologic prolactin-inhibiting factor (PIF). When dopamine is blocked at the pituitary: 1. Loss of tonic dopamine inhibition 2. Disinhibition of prolactin-releasing factors (TRH, VIP) 3. Unopposed prolactin secretion **Clinical Pearl:** Haloperidol's potent D2 blockade makes it one of the worst offenders for hyperprolactinemia among antipsychotics. Risperidone is intermediate; aripiprazole (partial D2 agonist) is safest. **Mnemonic:** **PROLACTIN RISK** = **P**otent D2 blockade (haloperidol > risperidone), **R**eceptor affinity (higher = more prolactin), **O**lder typicals worst, **L**ess with atypicals (except risperidone), **A**ripiprazole safest, **C**linical: gynecomastia/galactorrhea, **T**uberoinfundibular dopamine loss, **I**nhibition removed, **N**ew typicals better. ### Clinical Consequences **Haloperidol:** - Prolactin often >200 ng/mL - High risk of galactorrhea, amenorrhea, erectile dysfunction - Severe sexual side effects limit adherence **Risperidone:** - Prolactin often 100–150 ng/mL (lower than haloperidol) - Moderate sexual side effects - Still problematic; may warrant switching to aripiprazole or quetiapine ### Why Option 0 Is Correct Haloperidol's **stronger D2 antagonism** in the tuberoinfundibular pathway results in **greater prolactin elevation** compared to risperidone. This is the best discriminating feature: haloperidol causes more severe and sustained hyperprolactinemia.